Skip to content

Effect of Aminophylline on the depth of anesthesia and recovery of propofol

Comparing the effect of Aminophylline (vs. placebo) on the depth of anesthesia and recovery of propofol

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138812183520N1
Enrollment
154
Registered
2011-02-01
Start date
2010-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia. Other and unspecified general anaesthetics

Interventions

Intervention 1: Injection of aminophyline, 1 mg/kg in 10 ml of distilled water, at the end of surgery when spontaneous breathing begins and propofol infusion stops. Intervention 2: Injection of 10 ml
Prevention
Placebo
Injection of aminophyline, 1 mg/kg in 10 ml of distilled water, at the end of surgery when spontaneous breathing begins and propofol infusion stops.
Injection of 10 ml of distilled water at the end of surgery when spontaneous breathing begins and propofol infusion stops.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 18- 65, ASA I and II, scheduled for lower abdomen surgery, non pregnant, without any history of cardiac, pulmonary and nourologic disease, not using tranquilizers or opioids and theophyline group drugs. Exclusion criteria: hypotension during anesthesia that do not response to fluid therapy and need to decrease propofol infusion or need for using vasoactive drugs for treatment, need for more opioid during anesthesia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recovery time. Timepoint: once. Method of measurement: time from injection of drug or placebo to release from recovery.;Extubation time. Timepoint: once. Method of measurement: time from injection of drug or placebo to extubation.

Secondary

MeasureTime frame
Oxygen saturation. Timepoint: every 2 minutes from injection of drug or placebo to extubation then every 5 minutes till release from recovery. Method of measurement: pulse oximeter.;Heart rate. Timepoint: every 2 minutes from injection of drug or placebo to extubation then every 5 minutes till release from recovery. Method of measurement: pulse oximeter.;Mean arterial pressure. Timepoint: every 2 minutes from injection of drug or placebo to extubation then every 5 minutes till release from recovery. Method of measurement: automated blood pressure recorder.;Nausea and vomiting. Timepoint: as happens. Method of measurement: diagnosed by anesthetist.;Dysrythmia. Timepoint: as happens. Method of measurement: electrocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bijan Yazdi

Arak Univarsity of Medical Sciences

yazdi@arakmu.ac.ir , yazdibijan@hotmail.com+98 86 1222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026